The new drug from Merck was linked to several benefits for patients who are already on statins. If an oral PCSK9 inhibitor gains FDA approval, it could be a game-changer for the field of preventive medicine.
Starting in 2026, patients covered by UnitedHealthcare's Medicare Advantage and commercial plans will not have care reimbursed for instances of remote patient monitoring unless they have diagnosed heart failure or are pregnant and experiencing hypertension. The shift stands at odds with traditional Medicare, which added new claims codes for providers to use next year.
Nasser Mohamed, MD, a neurologist who operates a clinical practice in San Francisco, said an artificial intelligence system used by the autonomous taxi company led to him being denied multiple rides. He is seeking injunctive relief.
“Rapidly rising healthcare costs continue to be a top concern for members and their employers," the nation's largest commercial insurer wrote in a recent letter to an unidentified imaging group.
The independent, nonprofit—which provides objective advice on health policy—has picked Pamela K. Woodard, MD, and David G. Kirsch, MD, PhD, for the prestigious designation.
Such contract provisions are illegal in the state. However, doctors at Aspirus Health’s St. Luke’s Hospital said they’re being pressured to sign contract renewals with noncompete clauses under threat of termination.
New artificial intelligence technology could be used as a complimentary tool alongside low-dose GBCAs to enhance exams without sacrificing image quality.
The new drug from Merck was linked to several benefits for patients who are already on statins. If an oral PCSK9 inhibitor gains FDA approval, it could be a game-changer for the field of preventive medicine.
